Because HNSCC has been revealed as the second highest CD44-expressing cancer type in the Pan-Cancer Atlas [9], we first examined the reactivity of C44Mab-1 and C44Mab-46 in an oral SCC tissue, as a positive tissue control. This evidence concerns the gene CD44 and cancer.